Why the study?
Valvular hemangiomas are rare vascular anomalies with non-specific symptoms and few reported cases, with no previous reports of an arteriovenous hemangioma in a tricuspid localization.
This is the first reported case of an arteriovenous hemangioma with a tricuspid localization, suggesting possible involvement of endothelial-to-mesenchymal transition in its pathogenesis.
May inform differential diagnosis of rare cardiac masses; first report leaves open endothelial-to-mesenchymal transition in pathogenesis.
Valvular hemangiomas are uncommon vascular anomalies that appear on the surface of heart valves. They can cause an array of non-specific symptoms and are consequently rarely diagnosed, with only 31 such cases (including the present one) reported to date in the literature; the present case is the first report of an arteriovenous hemangioma with a tricuspid localization. During the preoperative echocardiographic examination for a ventricular septal defect, a mass was incidentally discovered on the tricuspid valve of a 9-month-old infant. The involved leaflet was surgically removed and sent to the pathology department for analysis and subsequently diagnosed as an arteriovenous hemangioma. The patient recovered well, with no local tumor recurrence or other complications. The microscopic examination showed multiple blood vessels which stained positive for the endothelial markers CD31 and CD34 and which did not express D2-40, normally found in lymphatic endothelia. Surprisingly, endothelial cells lining the vessels also showed positivity for SMA, a mesenchymal cell marker, indicating a possible involvement of endothelial-to-mesenchymal transition and its opposite process, mesenchymal-to-endothelial transition, in the pathogenesis of these vascular anomalies.
No takes yet. Share an insight, caveat, or question.
Neeter et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: